Medical Weightloss - Tirzepitide

Tirzepatide is a once-weekly injectable medication used to support blood sugar control and weight loss. It works differently than older medications because it activates two hormone receptors in the body instead of one.

Tirzepatide is the active ingredient in:

  • Mounjaro – FDA-approved for type 2 diabetes

  • Zepbound – FDA-approved for chronic weight management

woman weight loss

How Tirzepatide Works

Tirzepatide is a dual GIP and GLP-1 receptor agonist. That means it mimics two natural gut hormones:

  • GIP (Glucose-dependent Insulinotropic Polypeptide)

  • GLP-1 (Glucagon-Like Peptide-1)

Together, they help:

✔ Increase insulin when blood sugar is high
✔ Reduce glucagon (which raises blood sugar)
✔ Slow stomach emptying
✔ Decrease appetite
✔ Improve feelings of fullness

Because it works on two pathways, it often leads to greater weight loss compared to older GLP-1 medications.

What Is It Used For?

Type 2 Diabetes

Helps lower A1C and improve blood sugar control.

 

Medical Weight Loss

Prescribed for adults with: BMI ≥30

  • BMI ≥27 with weight-related conditions (like high blood pressure or sleep apnea)

Many patients experience significant weight reduction when combined with lifestyle changes.

Potential Benefits

Significant weight loss
Improved blood sugar control
Reduced appetite and cravings
Better metabolic health markers

Lower fasting glucose

Reduce insulin resistance

Decrease risk of progression from prediabetes to diabetes

MEDICAL WEIGHTLOSS SIDE EFFECTS

Common Side Effects

Like other GLP-1 medications, side effects may include:

Nausea, vomiting, diarrhea, constipation, and/or decreased appetite

These are usually mild and improve over time as the dose increases gradually.

FAQ

Frequently Asked Questions

How does tirzepatide work in the body?

Tirzepatide is a once-weekly injectable that targets two key hormones (GIP and GLP-1) to help control appetite, regulate blood sugar, and support fat loss, making it easier to achieve lasting metabolic health.

It reduces appetite, increases fullness, slows stomach emptying, and helps regulate blood sugar — leading to decreased calorie intake and fat loss over time.

 

Results vary, but clinical studies show patients may lose 15–22% of their body weight over time when combined with lifestyle changes.

 

Tirzepatide is injected once weekly, under the skin (abdomen, thigh, or upper arm).

 

Many patients notice appetite reduction within the first few weeks. Visible weight loss typically begins within 4–8 weeks, with continued progress over several months.

 

The most common side effects include:

  • Nausea

  • Constipation

  • Diarrhea

  • Decreased appetite

These are usually mild and improve as your body adjusts.

 

Yes. Tirzepatide works best when combined with healthy eating, movement, hydration, and lifestyle support. It is a tool — not a replacement — for long-term habits.

 

Adults with:

  • A BMI over 30

  • A BMI over 27 with weight-related conditions (such as high blood pressure or insulin resistance)
    A medical evaluation is required to determine eligibility.

The Food & Drug Administration has not evaluated the services provided. These products are not intended to diagnose, treat, cure, or prevent any disease. Always consult with your physician before beginning any therapy program. SkinTox Medical Spa  IV Hydration Bar, LLC DOES NOT PROMOTE EXCESS ALCOHOL CONSUMPTION.